Partner with Indero for Site Selection & Management
Indero is a dual focus CRO for dermatology & rheumatology clinical trials that identifies, qualifies and selects the most suitable sites for successful studies.
Strategic site selection for dermatology & rheumatology clinical trials, based on relevant experience in your indication, positive indicators in efficacy assessments, and proven recruitment track records.
(1) Site List
(2) Site Outreach
(3) Site Qualification Visit (SQV)
(4) Site Selection
Sites with an extensive patient database and a proven track record of on-time recruitment.
Senior Vice President, Clinical Development
Ventyx Biosciences, Inc.
“. . . From the initial synopsis development to the final stages of study conduct, the synergy between our teams was palpable and was underpinned by Indero’s strong relationships with sites, investigators and KOLs. . .”
With customized and consolidated outreach processes, Indero offers efficient and expedited site selection timelines. Here’s what makes our site selection and management services so successful:
“My work experience with Indero has been very positive. Their monitoring support has been crucial in achieving our research goals. So far, this partnership is a true success story. Their professionalism and expertise are commendable.”
Copernicus Medical Center, Gdansk
Wherever
You’re Going,
We’re all in.
Need help with your next study? We want to learn more. Fill out the form on the right and one of our experts will be in touch.
3530 Saint-Laurent Boulevard
Suite 300
Montreal, QC, H2X 2V1, Canada
© 2025 Indero. All Rights Reserved. Privacy Policy. Designed and developed by Altitude Marketing.
We are excited to announce that Innovaderm is rebranding our CRO division as Indero (in-dAIR-oh). This rebranding reflects our ongoing commitment to innovation and our expansion into the field of rheumatology, a therapeutic area closely linked to dermatology. As a dual-focus CRO specializing in both dermatology and rheumatology, this strategic decision marks a significant milestone for our organization, and we are eager to embark on this new chapter with our valued partners and clients. Innovaderm will continue to operate as a CRU for dermatology studies.
Our long-standing relationships with key opinion leaders and highly performing sites, result in optimized start-up processes that deliver strong results in the least amount of time. As part of our site evaluation, our team utilizes past performance metrics, recruitment projections based on competitive landscape, and detailed feasibility surveys to determine a site’s capabilities and interest in a study.
Our dedicated patient recruitment and advertising team integrates with the study team to tailor recruitment strategies, customize central ad campaigns, develop advertising creative, and continuously track and adapt recruitment goals. Our patient-centric approach is enhanced by Clinago, our technology enabled recruitment service.
We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.
We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.
